February 27, 2024 · Form 4 insider transaction
Leupin Nicolas bought 78,174 shares of NovoCure Limited at $16.30 per share, a transaction worth $1.27M. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Options to buy 78,174 ordinary shares will vest in equal installments on each of February 27, 2025, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates.